Home/Orchestra BioMed/David P. Hochman
DP

David P. Hochman

Chairman, Chief Executive Officer and Founder

Orchestra BioMed

Orchestra BioMed Pipeline

DrugIndicationPhase
AVIM Therapy (Atrioventricular Interval Modulation Therapy)Hypertension (particularly in patients indicated for pacemakers)Late-Stage Clinical (Pivotal)
Virtue® Sirolimus AngioInfusion™ Balloon (SAB)Coronary In-Stent Restenosis (ISR)Late-Stage Clinical (Pivotal)